APA (7th ed.) Citation

FL, A., GM, M., G, C., GV, B., CO, N., RF, A., . . . Jr, H. J. (2002). Induction chemotherapy followed by concomitant chemoradiation-induced regression of advanced cervical lymphadenopathy in head and neck cancer as a predictor of outcome. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 126(6), 602. https://doi.org/10.1067/mhn.2002.125606

Chicago Style (17th ed.) Citation

FL, Ampil, Mills GM, Caldito G, Burton GV, Nathan CO, Aarstad RF, Lian TF, Stucker FJ, and Hardin JC Jr. "Induction Chemotherapy Followed by Concomitant Chemoradiation-induced Regression of Advanced Cervical Lymphadenopathy in Head and Neck Cancer as a Predictor of Outcome." Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 126, no. 6 (2002): 602. https://doi.org/10.1067/mhn.2002.125606.

MLA (9th ed.) Citation

FL, Ampil, et al. "Induction Chemotherapy Followed by Concomitant Chemoradiation-induced Regression of Advanced Cervical Lymphadenopathy in Head and Neck Cancer as a Predictor of Outcome." Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, vol. 126, no. 6, 2002, p. 602, https://doi.org/10.1067/mhn.2002.125606.